This bill amends the Newborn Child Testing Act of September 9, 1965, to enhance the Newborn Child Screening and Follow-up Program in Pennsylvania. Specifically, it adds a new subparagraph to Section 3(a)(1) that mandates the inclusion of Gaucher disease in the list of diseases for which newborns must be screened. This addition aims to assist healthcare providers in determining the necessary treatments or services to prevent intellectual or physical disabilities and potential death in affected infants.

The bill emphasizes the importance of early detection and intervention for genetic diseases, thereby improving health outcomes for newborns. The changes will take effect 60 days after the bill is enacted, ensuring that the updated screening protocols can be implemented promptly to benefit infants and their families.